Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study-Reference-Cited by-同舟云学术

Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study

Published:2019-01-14 Issue:4 Volume:83 Page:639-647
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Gong Lei,Mao Weimin,Chen Qixun,Jiang Youhua,Fan Yun^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-019-03769-7/fulltext.html

Reference25 articles.

1. Di Pardo BJ, Bronson NW, Diggs BS, Thomas CR Jr, Hunter JG, Dolan JP (2016) The global burden of esophageal cancer: a disability-adjusted life-year approach. World J Surg 40(2):395–401. https://doi.org/10.1007/s00268-015-3356-2

2. Tang WR, Fang JY, Wu KS, Shi XJ, Luo JY, Lin K (2014) Epidemiological characteristics and prediction of esophageal cancer mortality in China from 1991 to 2012. Asian Pac J Cancer Prev 15(16):6929–6934

3. Domper Arnal MJ, Ferrandez Arenas A, Lanas Arbeloa A (2015) Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol 21(26):7933–7943. https://doi.org/10.3748/wjg.v21.i26.7933

4. Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, Takiyama W, Watanabe H, Isono K, Aoyama N, Makuuchi H, Tanaka O, Yamana H, Ikeuchi S, Kabuto T, Nagai K, Shimada Y, Kinjo Y, Fukuda H, Japan Clinical Oncology G (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 21(24):4592–4596. https://doi.org/10.1200/JCO.2003.12.095

5. Kranzfelder M, Schuster T, Geinitz H, Friess H, Buchler P (2011) Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer. Br J Surg 98(6):768–783. https://doi.org/10.1002/bjs.7455

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long noncoding RNAs as potential targets for overcoming chemoresistance in upper gastrointestinal cancers;Biomedicine & Pharmacotherapy;2024-10

2. scDiffCoAM: A complete framework to identify potential biomarkers for esophageal squamous cell carcinoma using scRNA-Seq data analysis;Journal of Biosciences;2024-08-06

3. The prognostic and predictive role of class III β-Tubulin and hENT1 expression in patients with advanced pancreatic ductal adenocarcinoma;Pancreatology;2024-03

4. SPARC expression in tumor microenvironment induces partial epithelial‐to‐mesenchymal transition of esophageal adenocarcinoma cells via cooperating with TGF‐β signaling;Cell Biology International;2022-10-13

5. Deciphering albumin-directed drug delivery by imaging;Advanced Drug Delivery Reviews;2022-06